Medicare Enrolled
Dr. James Lemert, M.D.
Urology Physician · Amarillo, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lemert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lemert?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lemert
Dr. James Lemert is an urology physician in Amarillo, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Lemert performed 24,100 Medicare services across 3,387 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lemert received a total of $5,648 from 33 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lemert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 3% volume in TX
$5,648 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,100
Medicare services
Top 3% in TX for urology physician
3,387
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,506 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 10,260 | $18 | $45 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,202 | $0 | $2 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
907 | $3 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
851 | $85 | $259 |
| PSA test (prostate cancer screening) | 527 | $18 | $70 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
497 | $7 | $50 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 492 | $134 | $1,000 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
159 | $58 | $591 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
129 | $18 | $70 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
84 | $24 | $75 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
83 | $5 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $109 | $397 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
64 | $190 | $650 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
61 | $23 | $275 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
57 | $20 | $66 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
57 | $11 | $50 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
53 | $72 | $375 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
52 | $86 | $530 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
48 | $141 | $1,075 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
44 | $19 | $103 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
39 | $8 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $59 | $175 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
34 | $50 | $275 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
31 | $91 | $345 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
28 | $39 | $95 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
25 | $173 | $740 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
25 | $306 | $1,050 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
25 | $71 | $276 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $102 | $350 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
23 | $15 | $48 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $111 | $590 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
20 | $34 | $375 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $24 | $400 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
16 | $138 | $650 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
14 | $3 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $136 | $475 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
11 | $102 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
85.1% medium
14.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,648
Total received (2018-2024)
Avg $807/year across 7 years
Top 35% in TX for urology physician
33
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,434 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$214 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$451
2023
$731
2022
$677
2021
$475
2020
$1,656
2019
$886
2018
$773
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
CIPLA USA INC.
$1,302
Astellas Pharma US Inc
$1,300
Dendreon Pharmaceuticals LLC
$440
Janssen Biotech, Inc.
$396
PFIZER INC.
$351
ABBVIE INC.
$332
Myriad Genetic Laboratories, Inc.
$221
Merck Sharp & Dohme LLC
$180
Amgen Inc.
$132
Sumitomo Pharma America, Inc.
$122
UroGen Pharma, Inc.
$119
AbbVie Inc.
$108
UROVANT SCIENCES INC
$78
Boston Scientific Corporation
$72
TOLMAR Pharmaceuticals, Inc.
$66
Janssen Products, LP
$60
Sun Pharmaceutical Industries Inc.
$40
Coloplast Corp
$35
Novartis Pharmaceuticals Corporation
$30
AbbVie, Inc.
$27
Laborie Medical Technologies Corp.
$27
NeoTract Inc.
$26
Allergan, Inc.
$25
Allergan Inc.
$23
Olympus America Inc.
$21
GENZYME CORPORATION
$18
SANOFI-AVENTIS U.S. LLC
$15
BAUDAX BIO INC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Intuitive Surgical, Inc.
$15
Tolmar, Inc.
$14
Antares Pharma, Inc.
$14
Endo Pharmaceuticals Inc.
$11
Top 3 companies account for 53.9% of total payments
Associated products mentioned in payments ›
ANJESO · BOTOX · BRACANALYSIS CDX · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · Prolia · REZUM · Soltive · SpaceOAR VUE System - 10mL · SpeediCath · TALZENNA · TOVIAZ · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · Xtandi · YONSA · ZEMDRI (PLAZOMICIN) · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $23 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
10
Per 100K population
8.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lemert is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lemert experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lemert performed 10,260 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lemert receive payments from pharmaceutical companies?
Yes. Dr. Lemert received a total of $5,648 from 33 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lemert's costs compare to other urology physicians in Amarillo?
Dr. Lemert's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lemert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Amarillo
Browse urology physicians in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
CIPLA USA INC. Payments to Doctors
See all physicians who received payments from CIPLA USA INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology